Powered by: Motilal Oswal
4/09/2021 9:42:35 AM | Source: ICICI Direct
Buy Varun Beverages Ltd For Target Rs.950 - ICICI Direct
News By Tags | #2334 #872 #3961 #1302 #3723
Buy Varun Beverages Ltd For Target Rs.950 - ICICI Direct

Covid-19 again adversely sways summer season…

About the stock Varun Beverages (VBL) is one of the largest franchisees of PepsiCo in the world. The company produces & distributes carbonated drinks, juices & packaged drinking water in six countries including. Some of the PepsiCo brands produced by VBL include Pepsi, Diet Pepsi, Seven-Up, Mirinda, Mountain Dew, Nimbooz, String, Slice, Tropicana, Aquafina, among others.

* The company has operations in India (except Andhra Pradesh, J&K & Ladakh), Sri Lanka, Nepal, Morocco, Zambia & Zimbabwe.

 

Q1CY21 Results: VBL reported a partial recovery in Q1FY22 results.

* Sales were up 49.4% YoY on a low base quarter

* EBITDA was at | 570.8 crore, up 51.1% YoY, with margins at 23.3%

* Consequent PAT was at | 318.8 crore (up 123% YoY)

 

What should investors do?

Varun Beverage share price has given 4x return (from | 195 in November 2016 to | 789 in August 2021).

* We roll over CY23 numbers with the expectation of full sales recovery in next two years

* We maintain our BUY rating on the stock.

Target Price and Valuation: We value the stock at | 950, valuing the business 22x CY23 EV / EBITDA.

 

Key triggers for future price performance:

* With the expected recovery in Covid-19 cases & vaccination drive, we expect VBL to clock optimum volumes in the 2022 peak summer season with operating margins perking up due to operating leverage.

* The company has launched several new brands in last two years i.e. String, ‘Mountain Dew ICE’, milk based beverages. New products would drive revenues, going forward.

* Given no major capex in the medium term, VBL would be able to completely de-leverage its balance sheet in the next three to four years with strong free cash flow generation.

 

Alternate Stock Idea: We also like Zydus Wellness in our FMCG coverage

* It is growing at a steady pace in nascent categories with a strong presence in health, nutrition space and margin expansion possibilities

* Trading at a significant discount to FMCG peers. BUY with TP of | 2,800

 

To Read Complete Report & Disclaimer Click Here

 

https://secure.icicidirect.com/Content/StaticData/Disclaimer.html

 

Above views are of the author and not of the website kindly read disclaimer

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here